No validated pharmacological target

The designation 'No validated pharmacological target' is a classification used in drug discovery and pharmacology to indicate that the specific molecular entity responsible for a compound's therapeutic effect has not been identified or confirmed. This status is frequently associated with drugs discovered through phenotypic screening, where a desired biological outcome is observed in a cell or organism without prior knowledge of the molecular trigger (Swinney & Anthony, 2011, Nature Reviews Drug Discovery). In these cases, the drug may exert its effects through complex polypharmacology, interacting with multiple low-affinity proteins, or by altering the physical-chemical environment of a cell rather than binding to a single high-affinity site. For biotech analysts, this classification represents a significant hurdle in rational drug design and the development of companion diagnostics, as the lack of a defined target makes it difficult to predict efficacy or safety across different patient populations (Hughes et al., 2011, British Journal of Pharmacology). Consequently, identifying and validating a specific target remains a primary goal in modern drug development to transition from empirical observation to targeted therapy.

Other names

Unknown targetUnidentified targetNon-specific mechanismPhenotypic target

Unknown or non-specific